Clinical trial
Pneumococcal Adult-dose Ranging Immunization Study
NCT00169234 · Kaiser Permanente, Other · Completed
Key facts
| NCT number | NCT00169234 |
|---|---|
| Title | Pneumococcal Adult-dose Ranging Immunization Study |
| Official title | Immunogenicity and Safety of Varying Doses of a 7-valent Conjugate Pneumococcal Vaccine in Adults 70-79 Years of Age Who Were Previously Vaccinated With the 23-valent Pneumococcal Polysaccharide Vaccine |
| Lead sponsor | Kaiser Permanente, Other |
| Collaborators | Centers for Disease Control and Prevention U.S. Fed |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pneumonia |
| Intervention type | Biological |
| Interventions | PCV7, Prevnar®, Pneumovax 23 |
| Enrollment | 220 |
| Start date | May 1, 2003 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: